Effect of Iron Versus Multiple Micronutrient Supplementation on Anemia in Preschool Children of Malaria-Endemic Area

NCT00628459 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 297

Last updated 2008-03-05

No results posted yet for this study

Summary

Some micronutrients are likely to interact with malaria parasite, leading to either synergistic or antagonist effect on malaria morbidity and therefore on hemoglobin response.

The purpose of this study is to investigate the effect of supplementation with iron or multiple micronutrients on anemia while integrated with malaria management in rural Burkinabe young anemic children with high prevalence of malaria.

Conditions

Interventions

DIETARY_SUPPLEMENT

micronutrient supplementation

Supplements are given daily, 5days/week, for 6 months, involving 15 mg iron (arm 1), 15 mg iron and 10 mg zinc (arm 2), or multiple micronutrient (arm 3): 15 mg iron, 10 mg zinc, 375 µg vitamin A, 5 µg vitamin D, 6 mg vitamin E, 0.5 mg vitamin B1, 0.5 mg vitamin B2, 6 mg niacin, 150 µg folic acid, 0.5 mg vitamin B6, 0.9 mg vitamin B12, 35 mg vitamin C, 10 µg vitamin K, 50 µg iodine, 0.6 mg copper.

Sponsors & Collaborators

  • Universite Libre de Bruxelles, Belgium

    collaborator UNKNOWN
  • Fonds pour la recherche scientifique médicale (FRSM), Belgium

    collaborator UNKNOWN
  • Centre National de la Recherche Scientifique et Technologique

    lead OTHER_GOV

Principal Investigators

  • Philippe Donnen, PhD · Université Libre de Bruxelles, Belgium

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
SINGLE_GROUP

Eligibility

Min Age
6 Months
Max Age
23 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-08-31
Primary Completion
2007-02-28
Completion
2008-02-29

Countries

  • Burkina Faso

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00628459 on ClinicalTrials.gov